Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

14
results for

"Hepatectomy"

Article category

Keywords

Publication year

"Hepatectomy"

Letter to the Editor

Citations

Citations to this article as recorded by  Crossref logo
  • Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion
    Jie Zeng, Hongyang Huang, Minchao Tang, Zheng Tao, Kaixiang Mo, Weijie Chen, Yuejiao Su, Jinting Su, Rong Liang, Yan Lin, Lequn Li, Guobin Wu, Xiaoling Luo, Jiazhou Ye, Rongyun Mai
    Journal of Hepatocellular Carcinoma.2025; Volume 12: 2825.     CrossRef
  • 8,218 View
  • 77 Download
  • 1 Web of Science
  • Crossref

Editorial

Hepatic neoplasm

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
Clin Mol Hepatol 2023;29(2):342-344.
Published online March 16, 2023
DOI: https://doi.org/10.3350/cmh.2023.0106

Citations

Citations to this article as recorded by  Crossref logo
  • Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma
    Weibin Zhang, Jia Dong, Yunfei Wu, Xiangnan Liang, Lida Suo, Liming Wang
    Biochemical Genetics.2025; 63(3): 2650.     CrossRef
  • Exploring the association between air pollution and the incidence of liver cancers
    Xin Wu, Xin Zhang, Xiaopeng Yu, Hongyuan Liang, Shaoshan Tang, Yao Wang
    Ecotoxicology and Environmental Safety.2025; 290: 117437.     CrossRef
  • α-Fetoprotein model versus Milan criteria in predicting outcomes after hepatic resection for hepatocellular carcinoma: multicentre study
    Chao Li, Yong-Kang Diao, Yi-Fan Li, Shao-Dong Lv, Xian-Ming Wang, Xue-Dong Wang, Qi-Xuan Zheng, Hong Wang, Han Liu, Kong-Ying Lin, Ying-Jian Liang, Ya-Hao Zhou, Wei-Min Gu, Ming-Da Wang, Lan-Qing Yao, Xin-Fei Xu, Jia-Hao Xu, Li-Hui Gu, Timothy M Pawlik, F
    BJS Open.2025;[Epub]     CrossRef
  • METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery
    Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatment
    Chang Zhao, Guchun Qin, Caixia Ling, Yang Zhao, Yunxi Huang, Zelong Jiang, Niqiang Zhou, Junjie Liu, Danke Su, Jinghang Jiang
    Journal of Cancer Research and Therapeutics.2025; 21(2): 465.     CrossRef
  • SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming
    Xin Jin, Xigan He, Runze Huang, Qinyu Liu, Lei Wang, Xuanci Bai, Yibin Wu, Yixiu Wang, Ziting Jiang, Yi Shi, Gautam Sethi, Lu Wang, Weiping Zhu
    Journal of Experimental & Clinical Cancer Research.2025;[Epub]     CrossRef
  • Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study
    Dongxu Yin, Zixuan Wang, Chao Li, Huixuan Fan, Zichao Tu, Yongkang Diao, Zijie Tang, Yongyi Zeng, Han Wu, Lihui Gu, Lanqing Yao, Xinfei Xu, Feng Shen, Mingda Wang, Tian Yang
    European Journal of Surgical Oncology.2025; 51(10): 110361.     CrossRef
  • Exosomal FOSL1 From Cancer-associated Fibroblasts Drives the Progression and Pro-tumorigenic M2 Macrophage Polarization of Hepatocellular Carcinoma By Activating PLAU Transcription
    Kai Bai, Ruopeng Liang, Jian Li, Kun Zhao
    Applied Biochemistry and Biotechnology.2025;[Epub]     CrossRef
  • Development of an UPLC-MS/MS method for quantification of donafenib and its metabolite in rat plasma: application to drug–drug interaction
    Yuxin Shen, Ruibin Li, Lu Cao, Jun Wu, Haoxin Fu, Peiqi Wang, Ren-ai Xu, Ling Ji
    Biochemical Pharmacology.2025; : 117540.     CrossRef
  • Artificial intelligence for enhancing decision-making in multidisciplinary tumor boards for HCC in China
    Dong Li, Haoyu Wang, Fei Gao, Xifeng Fu, Junfeng Han
    Hepatoma Research.2025;[Epub]     CrossRef
  • Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomy
    Jialu Fu, Jiafeng Chen, Lei Jin, Junfeng Huang, Shengwei Mao, Xuhui Zhao, Weifeng Qu, Rui Yang, Yi Wang, Yichao Bu, Zhiqi Guan, Jun Gao, Xiaoling Wu, Qianfu Zhao, Tianhao Chu, Guiqi Zhu, Yuan Fang, Yinghong Shi, Weiren Liu
    Clinics and Research in Hepatology and Gastroenterology.2025; : 102750.     CrossRef
  • Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio
    Shengzhe Lin, Yang Wang, Xinran Cai, Yunbin Ye, Yanling Chen
    International Immunopharmacology.2024; 128: 111477.     CrossRef
  • Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
    Ming-Da Wang, Yong-Kang Diao, Lan-Qing Yao, Zhong-Qi Fan, Ke-Chun Wang, Han Wu, Li-Hui Gu, Jia-Hao Xu, Chao Li, Guo-Yue Lv, Tian Yang
    iLIVER.2024; 3(1): 100083.     CrossRef
  • Cell-Membrane-Coated Metal–Organic Framework Nanocarrier Combining Chemodynamic Therapy for the Inhibition of Hepatocellular Carcinoma Proliferation
    Huaying Xie, Xuhua Xiao, Xiaoyuan Yi, Kunzhao Huang, Liyan Wang
    Pharmaceutics.2024; 16(5): 619.     CrossRef
  • Apolipoprotein H-based prognostic risk correlates with liver lipid metabolism disorder in patients with HBV-related hepatocellular carcinoma
    Yaming Liu, Zeyi Wu, Yiqun Zhao, Maochuan Zhen, Yanhong Wang, Qiusong Liu
    Heliyon.2024; 10(10): e31412.     CrossRef
  • Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression
    Wei Ding, Sujuan Xi, Kewei Gao, Danping Weng, Sheng Xu, Guoping Huang, Min Yu, Haiyan Yue, Jianguo Wang
    Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102403.     CrossRef
  • 9,038 View
  • 96 Download
  • 14 Web of Science
  • Crossref

Review

Hepatic neoplasm

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
Clin Mol Hepatol 2023;29(2):217-229.
Published online December 28, 2022
DOI: https://doi.org/10.3350/cmh.2022.0399
Hepatocellular carcinoma (HCC) is a major public health burden in Hong Kong, and chronic hepatitis B is the most common HCC etiology in our region. With the high case load, extensive local expertise on HCC has been accumulated. This article summarized local guidelines and real-life practice on HCC management in Hong Kong. For HCC surveillance, liver ultrasound and serum alpha-fetoprotein for periodic screening is recommended in viral hepatitis or cirrhotic patients, and this is adhered to in clinical practice. HCC diagnosis is not covered in local guidelines, yet our practice is in-line with regional guidelines, where diagnosis is usually achieved by cross-sectional imaging and without the need for histology. Our guidelines recommend using the Hong Kong Liver Cancer Staging for pre-treatment staging, yet we routinely use other widely-adopted systems such as the Barcelona Clinic Liver Cancer Staging and the Tumor-Node-Metastasis Staging as well. Our local guidelines have provided clear treatment algorithms for the whole range of HCC therapies, including resection, ablation, transplant, transarterial chemoembolization, transarterial radioembolization, stereotactic body radiation therapy, targeted therapy, and immunotherapy. Real-life treatment choices are largely in line with the guidelines, although treatment protocols are individualized, and availability of specific therapies can vary between centers. Overall, HCC guidelines in Hong Kong are tailored based on local expertise and our unique patient population. The guidelines are up-to-date and provide practical pathways to assist our routine practice. Regular updates of local guidelines are warranted to account for the rapidly evolving paradigm of HCC management.

Citations

Citations to this article as recorded by  Crossref logo
  • Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure
    Rex Wan-Hin Hui, Trevor Kwan-Hung Wu, Karen Cheuk-Ying Ho, Ryan Hin-Man Leung, Matthew Shing-Hin Chung, Danny Ka-Ho Wong, James Fung, Wai-Kay Seto, Lung Yi Mak, Man-Fung Yuen
    Gut.2026; 75(1): 119.     CrossRef
  • A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma
    J. M. John Britto, T Beula Bell
    Irish Journal of Medical Science (1971 -).2026;[Epub]     CrossRef
  • Advancements in locoregional therapy for advanced hepatocellular carcinoma: Emerging perspectives on combined treatment strategies
    Qi Liu, Renjie Zhang, Weixi Shen
    European Journal of Surgical Oncology.2025; 51(2): 109502.     CrossRef
  • Investigational RNA Interference Agents for Hepatitis B
    Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
    BioDrugs.2025; 39(1): 21.     CrossRef
  • Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR
    Yawen Wang, Xiaoyan Ma, Xuejie Chen, Zhenfan Wen, Chunyang Bi, Zhongren Xu, Wukun Liu
    European Journal of Medicinal Chemistry.2025; 283: 117137.     CrossRef
  • Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery
    Rex Wan-Hin Hui, Keith Wan-Hang Chiu, I-Cheng Lee, Chenlu Wang, Ho-Ming Cheng, Jianliang Lu, Xianhua Mao, Sarah Yu, Lok-Ka Lam, Lung-Yi Mak, Tan-To Cheung, Nam-Hung Chia, Chin-Cheung Cheung, Wai-Kuen Kan, Tiffany Cho-Lam Wong, Albert Chi-Yan Chan, Yi-Hsia
    Hepatology.2025; 82(2): 344.     CrossRef
  • Expanding treatment indications in chronic hepatitis B: Should we treat all patients?
    Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
    Hepatology International.2025; 19(2): 304.     CrossRef
  • Prospect of emerging treatments for hepatitis B virus functional cure
    Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
    Clinical and Molecular Hepatology.2025; 31(Suppl): S165.     CrossRef
  • Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategies
    Rex Wan-Hin Hui, James Fung, Wai-Kay Seto, Man-Fung Yuen, Lung-Yi Mak
    Hepatology International.2025; 19(4): 704.     CrossRef
  • Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study
    Tuong-Anh Mai-Phan, Trong-Kha Nguyen, Tri-Nhan Pham, Minh-Quang Tran, Kim-Long Le
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • The Prevailing Role of Diabetes Mellitus Among Cardiometabolic Risk Factors in Metabolic Dysfunction-associated Steatotic Liver Disease Prognostication
    Karen Cheuk-Ying Ho, Lung-Yi Mak
    Journal of Clinical and Experimental Hepatology.2025; 15(5): 103119.     CrossRef
  • 15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry
    Songgyung Kim, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Ki-Hun Kim, Jonggi Choi
    Gut and Liver.2025; 19(5): 746.     CrossRef
  • Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer
    Dorothy Cheuk‐Yan Yiu, Jimmy Che‐To Lai, Landon Long Chan, Grace Lai‐Hung Wong, Mandy Sze‐Man Lai, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Stephen Lam Chan, Terry Cheuk‐Fung Yip
    Alimentary Pharmacology & Therapeutics.2025;[Epub]     CrossRef
  • Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitors
    Rex Wan-Hin Hui, Matthew Shing-Hin Chung, Lu Li, Xianhua Mao, Chi-Leung Chiang, Carlos King-Ho Wong, Ian Chi-Kei Wong, Ka-Shing Cheung, Man-Fung Yuen, Wai-Kay Seto, Lung-Yi Mak
    JHEP Reports.2025; 7(11): 101578.     CrossRef
  • Development of a novel routine blood-based AI model for hepatocellular carcinoma screening—a territory-wide study
    K.-N. Kwok, K.-M. Chueng, S.J.-L. Lam, M. Seo, C.Y. Lau, P.Y.-M. Woo, H.-S. Lam, S.-M. Yip, S. Lam, O.-P. Chiu, W.W.Y. Sung, H.H.-W. Liu, K.K.-H. Bao, J.C.-H. Chow, S.K.-K. Ng, H.H.-Y. Yiu, D.C.C. Lam
    ESMO Gastrointestinal Oncology.2025; 10: 100241.     CrossRef
  • Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts
    Jacqueline Schönherr, Philipp Seifert, Falk Gühne, Thomas Winkens, Falk Rauchfuß, Utz Settmacher, Martin Freesmeyer, Robert Drescher
    Cancers.2024; 16(1): 235.     CrossRef
  • Hepatocellular carcinoma: Advances in systemic therapies
    Trevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
    F1000Research.2024; 13: 104.     CrossRef
  • ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
    Ryan Hin-Man Leung, Rex Wan-Hin Hui, Lung-Yi Mak, Xianhua Mao, Kevin Sze-Hang Liu, Danny Ka-Ho Wong, James Fung, Wai-Kay Seto, Man-Fung Yuen
    Journal of Hepatology.2024; 81(2): 218.     CrossRef
  • Hepatocellular carcinoma: Advances in systemic therapies
    Trevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
    F1000Research.2024; 13: 104.     CrossRef
  • Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
    Sergei Noskov, Anna Arefeva, Kseniia Radaeva, Igor Makarenko, Maria Gefen, Roman Drai
    Clinical Pharmacology in Drug Development.2024; 13(10): 1123.     CrossRef
  • Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy
    Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen, James Fung
    Expert Review of Gastroenterology & Hepatology.2023; 17(5): 443.     CrossRef
  • The prime time for management of hepatocellular carcinoma in Hong Kong
    Landon L. Chan, Stephen L. Chan
    Clinical and Molecular Hepatology.2023; 29(2): 345.     CrossRef
  • Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
    Yuri Cho, Bo Hyun Kim, Joong-Won Park
    Clinical and Molecular Hepatology.2023; 29(2): 252.     CrossRef
  • World Hepatitis Day 2023: Are we close to the target?
    Rex Wan-Hin Hui, James Fung
    Indian Journal of Medical Research.2023; 158(1): 1.     CrossRef
  • Global trends of targeted therapy for hepatocellular carcinoma: A bibliometric and visualized study from 2008 to 2022
    Xuan-Ang Yang, Rong Jin, Lei-Ming Zhang, Dong-Jian Ying
    Medicine.2023; 102(34): e34932.     CrossRef
  • 11,754 View
  • 282 Download
  • 24 Web of Science
  • Crossref

Editorial

Hepatic neoplasm

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
Bo Hyun Kim
Clin Mol Hepatol 2022;28(2):174-176.
Published online January 26, 2022
DOI: https://doi.org/10.3350/cmh.2021.0400

Citations

Citations to this article as recorded by  Crossref logo
  • Safety and efficacy of MRI-fluoroscopic guided microwave ablation of small subdiaphragmatic and pericardial liver tumors
    Daniel Markus Düx, Bennet Hensen, Julian Glandorf, Simon Schröer, Othmar Belker, Dominik Horstmann, Moritz Gutt, Kristina Imeen Ringe, Frank Wacker, Marcel Gutberlet
    Surgical Oncology Insight.2026; 3(1): 100206.     CrossRef
  • Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation Analysis
    Jiping Wang, Yunju Im, Rong Wang, Shuangge Ma
    Life.2024; 14(6): 661.     CrossRef
  • Mucins as Potential Biomarkers for Early Detection of Cancer
    Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser, Maneesh Jain
    Cancers.2023; 15(6): 1640.     CrossRef
  • Hepatocellular Carcinoma from a Hepatologist's Perspective
    Giovanni A. Roldan, Jacquelin Blomker, Elizabeth S. Aby
    Seminars in Interventional Radiology.2023; 40(06): 524.     CrossRef
  • 7,397 View
  • 134 Download
  • 4 Web of Science
  • Crossref

Review

Hepatic neoplasm

There has been controversy regarding the first-line treatment modality for the patients who have small solitary hepatocellular carcinoma (HCC); radiofrequency ablation (RFA) or percutaneous ethanol injection (PEI), surgical hepatic resection (HR) and liver transplantation (LT). For selection of treatment modality of HCC, it should be considered of hepatic reservoir function as well as the tumor stage. If the liver function is good enough, HR may be the first choice regardless of the tumor size. However, recent studies comparing RFA with resection showed comparable outcome and similar survival rates. RFA, HR and LT provide good outcome for patients who have small HCCs. RFA would be desired in patients who have below 3.0 cm in size and low alpha-fetoprotein (<200 ng/mL). However, in small HCC with high tumor marker, HR should be considered. Better patient selection for the ‘resection first’ approach and early detection of recurrence can achieve better outcomes of the salvage LT strategy. Another benefit of resection first strategy is that it make possible to do enlist of LT for patients before recurrence at high risk of HCC recurrence after resection on the basis of pathologic aggressiveness, microvascular invasion and/or satellites nodule. They should be applied appropriately according to the tumor size, location, tumor markers and underlying liver parenchymal disease.

Citations

Citations to this article as recorded by  Crossref logo
  • Association of primary hepatocellular carcinoma laterality with oncological outcomes for hepatic resection patients: A retrospective, multicenter, propensity score-matched study
    Okjoo Lee, Jaehong Jeong, So Kyung Yoon, Jun Chul Chung, Jongman Kim, Kwang-Woong Lee, Hyung Chul Kim
    Asian Journal of Surgery.2025; 48(4): 2241.     CrossRef
  • Preoperative Transarterial Chemoembolization for Resectable Single Hepatocellular Carcinoma: A Single-Center Cohort Study
    Sang-Hoon Kim, Ki-Hun Kim, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Young-In Yoon, Woo-Hyoung Kang, Eun-Kyoung Jwa, Byeong-Gon Na, Sung Min Kim, Sung-Gyu Lee
    Annals of Surgical Oncology.2025; 32(7): 5008.     CrossRef
  • A nomogram based on PNI and preoperative TACE can predict overall survival in patients with larger than 2 cm HCC after hepatectomy
    Huizhi Zhang, Chunyu Zhang, Run Hu, Kai Lei, Xingxing Wang, Zuojin Liu
    Updates in Surgery.2025; 77(4): 1113.     CrossRef
  • From conventional therapy to treatment with lipid-polymer hybrid nanoparticles for hepatocellular carcinoma
    Dina Farinha, Ana Bela Sarmento-Ribeiro, Henrique Faneca
    Materials Today Chemistry.2025; 47: 102870.     CrossRef
  • The Cost-Effectiveness Analysis of Radiofrequency Ablation Compared to Hepatic Resection for Resectable Small Hepatocellular Carcinoma in Thailand
    Nutcha Pinjaroen, Wantanee Kulpeng, Pisit Tangkijvanich, Taya Kitiyakara
    Clinical Therapeutics.2025; 47(8): 602.     CrossRef
  • Melanin@PLGA/Nuciferine Nanoparticles for Enhanced Photothermal Therapy of Hepatocellular Carcinoma by Promoting Autophagy
    Yingxuan Mao, Xinling Du, Weidong Wang, Tianxiu Dong, Mingwei Zhu, Jiamei Niu, Mingming Li, Jian Jiang, Linlin Han, Xiuhua Yang
    International Journal of Nanomedicine.2025; Volume 20: 11081.     CrossRef
  • Long-term outcomes of thermal ablation vs surgical resection for single small hepatocellular carcinoma
    Ying-Ming Gao, Sai-Kang Tang, Zhi-Wen Luo, Wei-Hua Zhi, Xue Yan, Xin Yin, Xin-Yu Bi, Yue Han
    World Journal of Clinical Oncology.2025;[Epub]     CrossRef
  • Mechanisms of rapid tumor progression after insufficient radiofrequency ablation of hepatocellular carcinoma
    Wenming Hou, Ge Ge, Xu Chen, Xinhua Xu
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features
    Sheng Chen, Yi-Jie Qiu, Qi Zhang, Xiu-Yun Lu, Yun-Lin Huang, Yi Dong, Wen-Ping Wang
    Ultrasound in Medicine & Biology.2024; 50(1): 39.     CrossRef
  • Perfluorobutane application value in microwave ablation of small hepatocellular carcinoma (<3 cm)
    Yanghong Pan, Delin Liu, Fei Liang, Zixiang Kong, Xu Zhang, Qinqin Ai
    Clinical Hemorheology and Microcirculation.2024; 87(3): 323.     CrossRef
  • Impact of preoperative transcatheter arterial chemoembolization (TACE) on postoperative long-term survival in patients with nonsmall hepatocellular carcinoma: a propensity score matching analysis
    Run Hu, Jie Xu, Hongxiang Wang, Jiaguo Wang, Kai Lei, Xiaoping Zhao, Huizhi Zhang, Ke You, Zuojin Liu
    BMC Cancer.2024;[Epub]     CrossRef
  • Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation Analysis
    Jiping Wang, Yunju Im, Rong Wang, Shuangge Ma
    Life.2024; 14(6): 661.     CrossRef
  • Meta analysis of radiofrequency ablation versus surgical resection in small and large nodule of hepatocellular carcinoma
    Rino A. Gani, Maria Teressa, Refael A. Budiman, Kemal F. Kalista, Cosmas Rinaldi A. Lesmana
    HPB.2024; 26(10): 1216.     CrossRef
  • Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma
    Xi Wang, Xinqun Chai, Ji Zhang, Ruiya Tang, Qinjunjie Chen
    BMC Cancer.2024;[Epub]     CrossRef
  • Retrospective Analysis of Radiofrequency Ablation in Patients with Small Solitary Hepatocellular Carcinoma: Survival Outcomes and Development of a Machine Learning Prognostic Model
    Qi-fan He, Yue Xiong, Yi-hui Yu, Xiang-chao Meng, Tian-xu Ma, Zhong-hua Chen
    Current Medical Science.2024; 44(5): 1006.     CrossRef
  • Comparison of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma patients: a SEER population-based propensity score matching study
    Xi Wang, Xinqun Chai, Ruiya Tang, Yunjie Xu, Qinjunjie Chen
    Updates in Surgery.2024; 76(8): 2755.     CrossRef
  • Comparison of the long‐term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation
    Ning‐Ning Zhang, Jian Zheng, Ying Wu, Jia‐Yu Lv, Shu‐Wen Zhang, Ya‐Min Zhang, Wen‐Tao Jiang, Tian‐Qiang Song, Victoria Kim, Samer Tohme, Tian Liu, Wei Zhang, Jie Gu, Ze‐Yu Wang, Yu‐Hong Suo, Shuai Wang, Wang Li, Li Zhang, Yan Xie, Yong‐He Zhou, Jian‐Yong
    Cancer Medicine.2023; 12(3): 2312.     CrossRef
  • Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry
    Felice Giuliante, Francesca Ratti, Elena Panettieri, Vincenzo Mazzaferro, Alfredo Guglielmi, Giuseppe M. Ettorre, Salvatore Gruttadauria, Fabrizio Di Benedetto, Umberto Cillo, Luciano De Carlis, Raffaele Dalla Valle, Alessandro Ferrero, Roberto Santambrog
    HPB.2023; 25(6): 674.     CrossRef
  • Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression
    Aleena Malik, Meghan P Jairam, Ronald Chow, Seyed A Mirshahvalad, Patrick Veit-Haibach, Charles B Simone
    Future Oncology.2023; 19(4): 279.     CrossRef
  • Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
    Sang Oh Yun, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
    Annals of Surgical Treatment and Research.2023; 104(4): 195.     CrossRef
  • Real world for management of hepatocellular carcinoma: a large population-based study
    Supatsri Sethasine, Nitipon Simasingha, Sarita Ratana-Amornpin, Varocha Mahachai
    Scandinavian Journal of Gastroenterology.2023; 58(10): 1153.     CrossRef
  • Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis
    Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman
    Transplantation Reviews.2023; 37(3): 100763.     CrossRef
  • Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study
    Guangzhao Shao, Zhongqi Fan, Wei Qiu, Guoyue Lv
    Journal of Cancer Research and Clinical Oncology.2023; 149(18): 16489.     CrossRef
  • Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
    Parata Chaiyana, Karjpong Techathuvanan, Supatsri Sethasine
    Scientific Reports.2023;[Epub]     CrossRef
  • Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial
    Zhenyu Wen, Junxiao Wang, Bo Tu, Yane Liu, Yuqing Yang, Li Hou, Xiang Yang, Xiaoyan Liu, Hui Xie
    Cancer Medicine.2023; 12(20): 20311.     CrossRef
  • Comparative long‐term outcomes of laparoscopic hepatectomy and radiofrequency ablation for hepatocellular carcinoma located in the anterolateral segments of the liver
    Sungho Kim, Chang Jin Yoon, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Moonhwan Kim, Boram Lee, Soyeon Ahn
    Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(3): 349.     CrossRef
  • Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
    Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh
    Annals of Surgical Treatment and Research.2022; 102(1): 1.     CrossRef
  • Achievement of textbook outcomes and comparisons with benchmark values after laparoscopic left lateral sectionectomy
    Mizelle D’Silva, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
    Updates in Surgery.2022; 74(4): 1299.     CrossRef
  • Association between achieving textbook outcomes and better survival after laparoscopic liver resection in the anterolateral segments in patients with hepatocellular carcinoma
    Mizelle D'Silva, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim, Yeongsoo Jo
    Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(8): 855.     CrossRef
  • A Case-Matched Analysis of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver According to Adaption of Developed Techniques
    Yujin Kwon, Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Munwhan Kim, Youngsoo Jo
    Medicina.2022; 58(4): 543.     CrossRef
  • A scoring system to predict the risk of major complications after laparoscopic liver resection in elderly patients with hepatocellular carcinoma
    Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Moonhwan Kim, Yeongsoo Jo
    Surgical Endoscopy.2022; 36(10): 7756.     CrossRef
  • Role of the pre- to postoperative alpha-fetoprotein ratio in the prognostic evaluation of liver cancer after radiofrequency ablation
    Biwei Luo, Linsen Liu, Jian’gang Bi, Shiyun Bao, Yusen Zhang
    The International Journal of Biological Markers.2022; 37(3): 306.     CrossRef
  • A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
    Shu-Wen Zhang, Ning-Ning Zhang, Wen-Wen Zhu, Tian Liu, Jia-Yu Lv, Wen-Tao Jiang, Ya-Min Zhang, Tian-Qiang Song, Li Zhang, Yan Xie, Yong-He Zhou, Wei Lu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Minor hepatectomy for hepatocellular carcinoma in a patient with portal hypertension: A case report and review of the literature
    Ting-Chun Tseng, Wen-Yao Yin
    Medicine.2022; 101(48): e32176.     CrossRef
  • Improved Outcomes of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver
    Yujin Kwon, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonwhan Kim
    World Journal of Surgery.2021; 45(4): 1178.     CrossRef
  • The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma
    Ji Hyun Lee, Beom Kyung Kim, Soo Young Park, Won Young Tak, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Dong Hyun Sinn, Seung Up Kim
    European Journal of Internal Medicine.2021; 89: 48.     CrossRef
  • External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
    Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
  • Fast calculation of 3D radiofrequency ablation zone based on a closed-form solution of heat conduction equation fitted by ex vivo measurements
    Rendong Chen, Jianfeng Zhang, Dexing Kong, Qiong Lou, Fang Lu
    Physics in Medicine & Biology.2021; 66(5): 055022.     CrossRef
  • Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
    Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2021; 13(23): 5892.     CrossRef
  • Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
    Riad Salem, Guy E. Johnson, Edward Kim, Ahsun Riaz, Vivian Bishay, Eveline Boucher, Kirk Fowers, Robert Lewandowski, Siddharth A. Padia
    Hepatology.2021; 74(5): 2342.     CrossRef
  • Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
    Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
    International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
  • A Survivorship-Period-Cohort Model for Cancer Survival: Application to Liver Cancer in Taiwan, 1997–2016
    Yan-Teng Peng, Fan-Tsui Meng, Shih-Yung Su, Chun-Ju Chiang, Ya-Wen Yang, Wen-Chung Lee
    American Journal of Epidemiology.2021; 190(9): 1961.     CrossRef
  • Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
    Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
    Gut and Liver.2021; 15(3): 420.     CrossRef
  • New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy
    Anil C. Anand, Subrat K. Acharya
    Journal of Clinical and Experimental Hepatology.2021; 11(3): 284.     CrossRef
  • New next-generation microwave thermosphere ablation for small hepatocellular carcinoma
    Hideyuki Tamai, Jumpei Okamura
    Clinical and Molecular Hepatology.2021; 27(4): 564.     CrossRef
  • Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
    Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
  • Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
    Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
  • The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
  • Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma
    Sang Yun Ha, Sangjoon Choi, Sujin Park, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh, Cheol-Keun Park
    Virchows Archiv.2020; 477(6): 807.     CrossRef
  • Tumor Diameter for Hepatocellular Carcinoma: Why Should Size Matter?
    Sertac Usta, Cuneyt Kayaalp
    Journal of Gastrointestinal Cancer.2020; 51(4): 1114.     CrossRef
  • Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
    Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2020; 12(9): 2527.     CrossRef
  • Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion


    Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2020; Volume 7: 403.     CrossRef
  • 11,197 View
  • 373 Download
  • 56 Web of Science
  • Crossref

Original Article

Hepatic neoplasm

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol 2018;24(2):144-150.
Published online January 16, 2018
DOI: https://doi.org/10.3350/cmh.2017.0041
Background/Aims
Portal vein invasion (PVI) is a poor prognostic factor in patients with hepatocellular carcinoma (HCC). We intended to compare the effects of surgical resection and transarterial chemoembolization (TACE) with additional radiation therapy (RT) in HCC patients with PVI.
Methods
The subjects comprised 43 patients who underwent surgical resection for HCC with PVI without previous treatment and another 43 patients who received TACE followed by RT (TACE+RT) as initial treatment who were matched for Child-Pugh class, tumor size, and extent of PVI. Disease progression and death after the treatment were examined, and progression-free survival (PFS) and overall survival (OS) were compared between groups. Predisposing factors affecting OS were analyzed using univariate and multivariate analyses in HCC patients with PVI.
Results
The subjects (Age [51, 24-74; median, range], Sex [81/13; male/female], Etiology [78/1/15; hepatitis B virus {HBV}/ hepatitis C virus {HCV}/non-HBV and non-HCV]) were followed for a median of 17 (2-68) months. There were no differences in clinical or tumor characteristics between the resection and TACE+RT groups. The cumulative PFS was not significantly different between groups. The median PFS was 5.6 and 4.0 months in the resection and TACE+RT groups, respectively. However, the cumulative OS was significantly longer in patients treated with resection than in those treated with TACE+RT (P=0.04). The median OS was 26.9 and 14.2 months in the resection and TACE+RT groups, respectively. Univariate and multivariate analyses revealed that surgical resection was an independent predictive factor for better survival outcome.
Conclusions
Surgical resection might be an effective treatment in HCC patients with PVI.

Citations

Citations to this article as recorded by  Crossref logo
  • Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
    Sujin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
    Journal of Liver Cancer.2023; 23(1): 177.     CrossRef
  • Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis
    Han Ah Lee, Yeon Seok Seo, In-Soo Shin, Won Sup Yoon, Hye Yoon Lee, Chai Hong Rim
    International Journal of Surgery.2022; 104: 106753.     CrossRef
  • Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study
    Hye Kyung Hyun, Eun Ju Cho, Soo Young Park, Young Mi Hong, Soon Sun Kim, Hwi Young Kim, Nae-Yun Heo, Jung Gil Park, Dong Hyun Sinn, Wonseok Kang, Song Won Jeong, Myeong Jun Song, Hana Park, Danbi Lee, Yong Sun Lee, Sung Bum Cho, Chan Sik An, Hyung Jin Rhe
    Digestive Diseases and Sciences.2021; 66(7): 2427.     CrossRef
  • Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma
    Soojin Kim, Kyung Hyun Kim, Beom Kyung Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim, Seung Up Kim
    Journal of Gastroenterology and Hepatology.2021; 36(5): 1317.     CrossRef
  • Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
    Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
  • Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
    David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
    Cancers.2021; 14(1): 67.     CrossRef
  • Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
    Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2020; 12(9): 2527.     CrossRef
  • Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion


    Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2020; Volume 7: 403.     CrossRef
  • Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study
    Dong‐won Lee, Hyung Joon Yim, Yeon Seok Seo, Seong Kyun Na, Seung Young Kim, Sang Jun Suh, Jong Jin Hyun, Sung Woo Jung, Young Kul Jung, Ja Seol Koo, Ji Hoon Kim, Jong Eun Yeon, Sang Woo Lee, Kwan Soo Byun, Soon Ho Um
    Liver International.2019; 39(6): 1109.     CrossRef
  • Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
    Ping Li, YanZhen Xu, Qinle Zhang, Yu Li, Wenxian Jia, Xiao Wang, Zhibin Xie, Jiayi Liu, Dong Zhao, Mengnan Shao, Suixia Chen, Nanfang Mo, Zhiwen Jiang, Liuyan Li, Run Liu, Wanying Huang, Li Chang, Siyu Chen, Hongtao Li, Wenpu Zuo, Jiaquan Li, Ruoheng Zhan
    Cancer Cell International.2019;[Epub]     CrossRef
  • Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
    Jin Wook Chung
    Clinical and Molecular Hepatology.2018; 24(2): 135.     CrossRef
  • 12,174 View
  • 181 Download
  • 12 Web of Science
  • Crossref

Reviews

Hepatic neoplasm

Current status of laparoscopic liver resection for hepatocellular carcinoma
Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy
Clin Mol Hepatol 2016;22(2):212-218.
Published online June 15, 2016
DOI: https://doi.org/10.3350/cmh.2016.0026
Laparoscopic liver resection (LLR) is becoming widely accepted for the treatment of hepatocellular carcinoma (HCC). Laparoscopic left lateral sectionectomy and minor laparoscopic liver resection are now considered standard approaches, especially for tumors located in the anterolateral segments of the liver. Laparoscopic left lateral sectionectomy in adult donors is also gaining acceptance for child liver transplantation in many centers. Major LLRs, including left hepatectomy and right hepatectomy, have been recently attempted. Laparoscopic donor hepatectomy is becoming more popular owing to increasing demand from young living donors who appreciate its minimal invasiveness and excellent cosmetic outcomes. Several centers have performed total laparoscopic donor right hepatectomy in adult-to-adult living donor liver transplantation. Many meta-analyses have shown that LLR is better than open liver resection in terms of short-term outcomes, principally cosmetic outcomes. Although no randomized control trials have compared LLR with open liver resection, the long-term oncologic outcomes were similar for both procedures in recent case-matched studies.

Citations

Citations to this article as recorded by  Crossref logo
  • Analysis of influencing factors for achieving textbook outcome after laparoscopic right posterior sectionectomy of hepatocellular carcinoma
    Changyan Zhu, Jiali Wu, Xiuyuan Wang, Weixing Zhang, Zhiqiang Fu, Yuqiu Hu
    European Journal of Surgical Oncology.2025; 51(10): 110328.     CrossRef
  • Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
    Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
    Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
  • Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
    Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
    Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
  • Robotic versus laparoscopic liver resection for liver malignancy: a systematic review and meta-analysis of propensity score-matched studies
    Zhang-tao Long, Hua-jian Li, Hao Liang, Ya-chen Wu, Sajid Ameer, Xi-lin Qu, Zhi-qiang Xiang, Qian Wang, Xiao-ming Dai, Zhu Zhu
    Surgical Endoscopy.2024; 38(1): 56.     CrossRef
  • Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma
    Jingjing Yu, Peng Zhu, Linlin Shi, Na Gao, Yani Li, Chang Shu, Ying Xu, Ying Yu, Junqing He, Dingming Guo, Xiaoman Zhang, Xiangfeng Wang, Sirui Shao, Wei Dong, Yuwei Wang, Wei Zhang, Wanguang Zhang, Wei-Hua Chen, Xiaoping Chen, Zhi Liu, Xiangliang Yang, B
    Cell Host & Microbe.2024; 32(1): 131.     CrossRef
  • Comparison of the outcomes between ultrasonic devices and clamping in hepatectomy: a meta-analysis
    Zhang-neng Yu, Liang-liang Xu, Lian Li, Hua Zhang, Yong-yuan Ma, Liang Wang, Jin-ting Jiang, Ming Zhang
    World Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
    Henrique A. Lima, Yutaka Endo, Zorays Moazzam, Laura Alaimo, Chanza Shaikh, Muhammad M. Munir, Vivian Resende, Alfredo Guglielmi, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, It
    Journal of Surgical Oncology.2023; 127(3): 374.     CrossRef
  • Delimiting Low Level of Difficulty Scoring System Based on the Extent of Resection Difficulty Scoring System for Laparoscopic Liver Resection
    Tao Liu, Yangyang Ou, Taiyun Huang, Zhaosong Xue, Ming Yao, Jianjun Li, Yubin Huang, Xiaoyong Cai, Yihe Yan
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2023; 33(7): 615.     CrossRef
  • Comparative Study of Long-Term Outcomes of Laparoscopic Liver Resection versus Radiofrequency Ablation for Single Small Hepatocellular Carcinoma Located in Left Lateral Segments of the Liver
    MeeYoung Kang, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, Jinju Kim, Chang Jin Yoon
    Medicina.2023; 59(6): 1063.     CrossRef
  • Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis
    Antonella Delvecchio, Maria Conticchio, Umberto Riccelli, Valentina Ferraro, Francesca Ratti, Maximiliano Gelli, Ferdinando M. Anelli, Alexis Laurent, Giulio C. Vitali, Paolo Magistri, Giacomo Assirati, Emanuele Felli, Taiga Wakabayashi, Patrick Pessaux,
    HPB.2022; 24(6): 933.     CrossRef
  • Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma
    Gianluca Cassese, Ho-Seong Han, Boram Lee, Hae Won Lee, Jai Young Cho, Roberto Troisi
    Cancers.2022; 14(8): 2012.     CrossRef
  • A Case-Matched Analysis of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver According to Adaption of Developed Techniques
    Yujin Kwon, Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Munwhan Kim, Youngsoo Jo
    Medicina.2022; 58(4): 543.     CrossRef
  • Long-Term Outcomes of Laparoscopic Liver Resection for Centrally Located Hepatocellular Carcinoma
    Hyo Jun Kim, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Yeongsoo Jo, Meeyouong Kang, Yeshong Park, Eunhye Lee
    Medicina.2022; 58(6): 737.     CrossRef
  • The APR triangle: A practical zone in the Glissonean approach to laparoscopic anatomical right hepatectomy
    Jie Chen, Ziyu Zhang, Rui Zhou, Anzhi Wang, Jun Cao, Yajin Chen
    iLIVER.2022; 1(3): 176.     CrossRef
  • Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma
    Wangrui Liu, Shuai Zhao, Wenhao Xu, Jianfeng Xiang, Chuanyu Li, Jun Li, Han Ding, Hailiang Zhang, Yichi Zhang, Haineng Huang, Jian Wang, Tao Wang, Bo Zhai, Lei Pan
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Feasibility of Solo Single-Incision Laparoscopic Surgery in Non-anatomical Minor Liver Resection: a Propensity Score-Matched Analysis
    In Gun Hyun, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Kil Hwan Kim, Sunjong Han
    Journal of Gastrointestinal Surgery.2021; 25(3): 681.     CrossRef
  • Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach
    Xiu-Tao Fu, Zheng Tang, Jia-Feng Chen, Ying-Hong Shi, Wei-Ren Liu, Qiang Gao, Guang-Yu Ding, Kang Song, Xiao-Ying Wang, Jian Zhou, Jia Fan, Zhen-Bin Ding
    Surgical Endoscopy.2021; 35(2): 910.     CrossRef
  • Laparoscopic major hepatectomy for hepatocellular carcinoma in elderly patients: a multicentric propensity score‑based analysis
    Antonella Delvecchio, Maria Conticchio, Francesca Ratti, Maximiliano Gelli, Ferdinando Massimiliano Anelli, Alexis Laurent, Giulio Cesare Vitali, Paolo Magistri, Giacomo Assirati, Emanuele Felli, Taiga Wakabayashi, Patrick Pessaux, Tullio Piardi, Fabrizio
    Surgical Endoscopy.2021; 35(7): 3642.     CrossRef
  • Influence of Large Grafts Weighing ≥ 1000 g on Outcome of Pure Laparoscopic Donor Right Hepatectomy
    Worakitti Lapisatepun, Suk Kyun Hong, Kwangpyo Hong, Eui Soo Han, Jeong-Moo Lee, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh
    Journal of Gastrointestinal Surgery.2021; 25(8): 1980.     CrossRef
  • Improved Outcomes of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver
    Yujin Kwon, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonwhan Kim
    World Journal of Surgery.2021; 45(4): 1178.     CrossRef
  • The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
    Jie Zhu, Peiqi Fang, Chong Wang, Meixiu Gu, Baishen Pan, Wei Guo, Xinrong Yang, Beili Wang
    Cancer Medicine.2021; 10(22): 7977.     CrossRef
  • Clinical Study on the Efficacy of Laparoscopic Hepatectomy and Its Influence on the Expression of Serum VEGF, FGF, and Immune Function
    Zhengyong Tang, Yi Tang, Tianqi Liu, Rongjun Liu, Shaowei Xie, Dongyi Xie, Jianrong Yang, Yuntian Tang, Songwen Tan
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • Dorsal approach with Glissonian approach for laparoscopic right anatomic liver resections
    Shaohe Wang, Yang Yue, Wenjie Zhang, Qiaoyu Liu, Beicheng Sun, Xitai Sun, Decai Yu
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Risk factors and long-term implications of unplanned conversion during laparoscopic liver resection for hepatocellular carcinoma located in anterolateral liver segments
    Hyojin Shin, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim, Yeongsoo Jo
    Journal of Minimally Invasive Surgery.2021; 24(4): 191.     CrossRef
  • Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes
    Dong Ho Lee, Jing Woong Kim, Jeong Min Lee, Jong Man Kim, Min Woo Lee, Hyunchul Rhim, Young Hoe Hur, Kyung-Suk Suh
    Liver Cancer.2021; 10(1): 25.     CrossRef
  • Laparoscopic segment 4 resection including middle hepatic vein with vaginal extraction of the specimen
    Boram Lee, YoungRok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han
    Surgical Oncology.2020; 32: 46.     CrossRef
  • Liver Resection for Hepatocellular Carcinoma and the Barcelona Clinic Liver Cancer Criteria: Is It Time to Push the Limits?
    Leon Naar, Ioannis Hatzaras
    Annals of Surgical Oncology.2020; 27(7): 2122.     CrossRef
  • When should we choose a laparoscopic approach? A high-volume center recommendation score
    Benone-Iulian Mosteanu, Ho-Seong Han, Jai Young Cho, Boram Lee
    Surgical Oncology.2020; 34: 208.     CrossRef
  • Solo single‐incision laparoscopic liver resection: a cohort series
    Mohamed Rabie Saad, YoungRok Choi, Ho‐Seong Han, Yoo‐Seok Yoon, Jai Young Cho, Jun Suh Lee, Bo Ram Lee
    ANZ Journal of Surgery.2020; 90(6): 1108.     CrossRef
  • Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia
    Yueh‐Wei Liu, Chee‐Chien Yong, Chih‐Che Lin, Chih‐Chi Wang, Chao‐Long Chen, Yu‐Fan Cheng, Jing‐Houng Wang, Yi‐Hao Yen, Chien‐Hung Chen
    Journal of Surgical Oncology.2020; 122(8): 1587.     CrossRef
  • The Contemporary Role of Resection and Ablation in Colorectal Cancer Liver Metastases
    Mariam F. Eskander, Christopher T. Aquina, Aslam Ejaz, Timothy M. Pawlik
    Digestive Disease Interventions.2020;[Epub]     CrossRef
  • Long-Term Oncological Outcomes of Laparoscopic Liver Resection for Solitary Hepatocellular Carcinoma: Comparison of Anatomical and Nonanatomical Resection Using Propensity Score Matching Analysis
    Chan Woo Cho, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2019; 29(6): 752.     CrossRef
  • Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC
    Dong Ho Lee, Jeong Min Lee, Mi Hye Yu, Bo Yun Hur, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon, Yoon Jun Kim, Jeong-Hoon Lee, Su Jong Yu, Joon Koo Han
    European Radiology.2019; 29(6): 3122.     CrossRef
  • Laparoscopic Versus Open Hepatectomy in Short- and Long-Term Outcomes of the Hepatocellular Carcinoma Patients with Cirrhosis: A Systematic Review and Meta-Analysis
    Song Jiang, Zhaoying Wang, Mingrui Ou, Qing Pang, Dongwei Fan, Peiyuan Cui
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2019;[Epub]     CrossRef
  • Laparoscopic liver resection in segment 7: Hepatic vein first approach with special reference to sufficient resection margin
    Boram Lee, Jai Young Cho, YoungRok Choi, Yoo-Seok Yoon, Ho-Seong Han
    Surgical Oncology.2019; 30: 87.     CrossRef
  • A Single Center Experience for a Feasibility of Totally Laparoscopic Living Donor Right Hepatectomy
    Min-Su Park
    The Journal of Minimally Invasive Surgery.2019; 22(2): 47.     CrossRef
  • A Single Center Experience for a Feasibility of Totally Laparoscopic Living Donor Right Hepatectomy
    Soo Kyung Lee, Young Seok Han, Heontak Ha, Jaryung Han, Jae Min Chun
    The Journal of Minimally Invasive Surgery.2019; 22(2): 61.     CrossRef
  • Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
    Chen Lu, Dawei Rong, Betty Zhang, Wubin Zheng, Xuehao Wang, Ziyi Chen, Weiwei Tang
    Molecular Cancer.2019;[Epub]     CrossRef
  • Laparoscopic Versus Open Left Lateral Segmentectomy for Large Hepatocellular Carcinoma: A Propensity Score–Matched Analysis
    Xiu-Tao Fu, Zheng Tang, Ying-Hong Shi, Jian Zhou, Wei-Ren Liu, Qiang Gao, Guang-Yu Ding, Jia-Feng Chen, Kang Song, Xiao-Ying Wang, Jia Fan, Zhen-Bin Ding
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2019; 29(6): 513.     CrossRef
  • Laparoscopic liver resection of hepatocellular carcinoma located in segments 7 or 8
    Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Jae Seong Jang, Seong Uk Kwon, Sungho Kim, Jang Kyu Choi
    Surgical Endoscopy.2018; 32(2): 872.     CrossRef
  • Outcomes of major laparoscopic liver resection for hepatocellular carcinoma
    Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Sungho Kim, Kilhwan Kim, In Gun Hyun
    Surgical Oncology.2018; 27(1): 31.     CrossRef
  • Comparative Performance of the Complexity Classification and the Conventional Major/Minor Classification for Predicting the Difficulty of Liver Resection for Hepatocellular Carcinoma
    Jae Seong Jang, Jai Young Cho, Soyeon Ahn, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Seong Uk Kwon, Sungho Kim, Hanisah Guro
    Annals of Surgery.2018; 267(1): 18.     CrossRef
  • Practical guidelines for performing laparoscopic liver resection based on the second international laparoscopic liver consensus conference
    Jai Young Cho, Ho-Seong Han, Go Wakabayashi, Olivier Soubrane, David Geller, Nicholas O'Rourke, Joseph Buell, Daniel Cherqui
    Surgical Oncology.2018; 27(1): A5.     CrossRef
  • Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway
    Xueran Chen, Shangrong Zhang, Zhen Wang, Fengsong Wang, Xinwang Cao, Quan Wu, Chenggang Zhao, Huihui Ma, Fang Ye, Hongzhi Wang, Zhiyou Fang
    Journal of Experimental & Clinical Cancer Research.2018;[Epub]     CrossRef
  • Glissonian approach combined with major hepatic vein first for laparoscopic anatomic hepatectomy
    De-Cai Yu, Xing-Yu Wu, Xi-Tai Sun, Yi-Tao Ding
    Hepatobiliary & Pancreatic Diseases International.2018; 17(4): 316.     CrossRef
  • Correlation between Resection Margin and Disease Recurrence with a Restricted Cubic Spline Model in Patients with Resected Hepatocellular Carcinoma
    Woohyung Lee, Ho-Seong Han, Soyeon Ahn, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi
    Digestive Surgery.2018; 35(6): 520.     CrossRef
  • Precision and innovation in minimal invasion: A report of 2018 International Conference of Minimally Invasive Surgery, West Lake Summit
    Qingjie Zeng, Jin Wang
    Laparoscopic, Endoscopic and Robotic Surgery.2018; 1(3): 55.     CrossRef
  • Stapleless laparoscopic left lateral sectionectomy for hepatocellular carcinoma: reappraisal of the Louisville statement by a young liver surgeon
    Chao-Wei Lee, Hsin-I Tsai, Hao-Tsai Cheng, Wei-Ting Chen, Heng-Yuan Hsu, Chien-Chih Chiu, Yi-Ping Liu, Tsung-Han Wu, Ming-Chin Yu, Wei-Chen Lee, Miin-Fu Chen
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • Solo Reduced Port Laparoscopic Left Lateral Sectionectomy
    YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Sungho Kim, In Gun Hyun, Kil Hwan Kim
    The Journal of Minimally Invasive Surgery.2018; 21(3): 133.     CrossRef
  • Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches
    Hanisah Guro, Jin Won Kim, YoungRok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han
    Surgical Oncology.2017; 26(2): 146.     CrossRef
  • Prediction of surgical outcomes of laparoscopic liver resections for hepatocellular carcinoma by defining surgical difficulty
    Mohan Periyasamy, Jai Young Cho, Soyeon Ahn, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Jae Seong Jang, Seong Uk Kwon, Sungho Kim, Jang Kyu Choi, Hanisah Guro
    Surgical Endoscopy.2017; 31(12): 5209.     CrossRef
  • Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting
    Zhao-Chong Zeng, Jinsil Seong, Sang Min Yoon, Jason Chia-Hsien Cheng, Ka-On Lam, Ann-Shing Lee, Ada Law, Jian-Ying Zhang, Yong Hu
    Liver Cancer.2017; 6(4): 264.     CrossRef
  • Update on current problems in colorectal liver metastasis
    Jeffrey Chakedis, Malcolm H. Squires, Eliza W. Beal, Tasha Hughes, Heather Lewis, Anghela Paredes, Mazen Al-Mansour, Steven Sun, Jordan M. Cloyd, Timothy M. Pawlik
    Current Problems in Surgery.2017; 54(11): 554.     CrossRef
  • Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
    Jian-Hong Zhong, Ning-Fu Peng, Jian-Hong Gu, Ming-Hua Zheng, Le-Qun Li
    World Journal of Hepatology.2017; 9(4): 167.     CrossRef
  • Current Status of Laparoscopic Liver Resection: Experiences from Tertiary Center
    Mohan Periyasamy, Ho-Seong Han, Jai Young Cho, Yoo-Seok Yoon, Young Rok Choi, Jae Seong Jang, Seong Uk Kwon, Sungho Kim, Jang Kyu Choi, Hanisah Guro
    The Journal of Minimally Invasive Surgery.2017; 20(4): 125.     CrossRef
  • 17,693 View
  • 305 Download
  • 57 Web of Science
  • Crossref

Liver development and regeneration

Clinical implications of advances in liver regeneration
Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi
Clin Mol Hepatol 2015;21(1):7-13.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.7

Remarkable advances have been made recently in the area of liver regeneration. Even though liver regeneration after liver resection has been widely researched, new clinical applications have provided a better understanding of the process. Hepatic damage induces a process of regeneration that rarely occurs in normal undamaged liver. Many studies have concentrated on the mechanism of hepatocyte regeneration following liver damage. High mortality is usual in patients with terminal liver failure. Patients die when the regenerative process is unable to balance loss due to liver damage. During disease progression, cellular adaptations take place and the organ microenvironment changes. Portal vein embolization and the associating liver partition and portal vein ligation for staged hepatectomy are relatively recent techniques exploiting the remarkable progress in understanding liver regeneration. Living donor liver transplantation is one of the most significant clinical outcomes of research on liver regeneration. Another major clinical field involving liver regeneration is cell therapy using adult stem cells. The aim of this article is to provide an outline of the clinical approaches being undertaken to examine regeneration in liver diseases.

Citations

Citations to this article as recorded by  Crossref logo
  • Human umbilical cord mesenchymal stem cells enhance liver regeneration and decrease collagen content in fibrosis mice after partial hepatectomy by activating Wnt/β-catenin signaling
    Xuewei Li, Jinghui Feng, Haiqin Cheng, Ning Jin, Shanshan Jin, Zhizhen Liu, Jun Xu, Jun Xie
    Acta Biochimica et Biophysica Sinica.2025; 57(4): 604.     CrossRef
  • From Cells to Exosomes: a Review of Non-Surgical Biotherapeutic-Based Strategies for Liver Regeneration in the Face of End-Stage Diseases
    Fatemeh Askari Yazdian, Matin Mojaveri Samak, Amirhossein Larijani, Mohammad Taghi Ashoobi, Mohadese Kharaqani, Mohammad Amin Ghezel, Zahra Barabadi, Elham Vojoudi
    Stem Cell Reviews and Reports.2025; 21(6): 1669.     CrossRef
  • Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
    Qi Liu, Senyan Wang, Jing Fu, Yao Chen, Jing Xu, Wenjuan Wei, Hao Song, Xiaofang Zhao, Hongyang Wang
    Clinical and Translational Medicine.2024;[Epub]     CrossRef
  • Interleukin‐33 facilitates liver regeneration through serotonin‐involved gut‐liver axis
    Yankai Wen, Christoph Emontzpohl, Long Xu, Constance L. Atkins, Jong‐Min Jeong, Yang Yang, Kangho Kim, Chuan Wu, Shizuo Akira, Cynthia Ju
    Hepatology.2023; 77(5): 1580.     CrossRef
  • Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma
    Yanchao Xu, Yunzheng Li, Yanjun Lu, Weihong Wang, Zhaowu Lian, Zijie Wu, Binghua Li, Decai Yu
    Journal of Hepatocellular Carcinoma.2023; Volume 10: 2197.     CrossRef
  • Clinical Application of Regenerative Medicine in the Treatment of End-Stage Liver Diseases
    洪 刘
    Advances in Clinical Medicine.2022; 12(08): 7256.     CrossRef
  • Predicting liver regeneration following major resection
    Karolin Dehlke, Linda Krause, Silvana Tyufekchieva, Anastasia Murtha-Lemekhova, Philipp Mayer, Artyom Vlasov, Ursula Klingmüller, Nikola S. Mueller, Katrin Hoffmann
    Scientific Reports.2022;[Epub]     CrossRef
  • Comparing various scoring systems in the treatment of hepatocellular carcinoma with ALPPS
    Yan Xu, Xiaoling Hu, Jiangbin Li, Rui Dong
    International Journal of Surgery: Global Health.2021; 4(2): e44.     CrossRef
  • Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State
    Hyun Kyoung Kang, Madina Sarsenova, Da-Hyun Kim, Min Soo Kim, Jin Young Lee, Eun-Ah Sung, Myung Geun Kook, Nam Gyo Kim, Soon Won Choi, Vyacheslav Ogay, Kyung-Sun Kang
    Cells.2021; 10(5): 1268.     CrossRef
  • Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication
    Gyeong-Seok Lee, Hee-Yeon Jeong, Hyeon-Gung Yang, Young-Ran Seo, Eui-Gil Jung, Yong-Seok Lee, Kung-Woo Nam, Wan-Jong Kim
    Molecules.2021; 26(10): 2895.     CrossRef
  • Geometrical model of lobular structure and its importance for the liver perfusion analysis
    Eduard Rohan, Jana Camprová Turjanicová, Václav Liška, Adélia Sequeira
    PLOS ONE.2021; 16(12): e0260068.     CrossRef
  • Small-molecule-mediated reprogramming: a silver lining for regenerative medicine
    Yohan Kim, Jaemin Jeong, Dongho Choi
    Experimental & Molecular Medicine.2020; 52(2): 213.     CrossRef
  • Extent of liver resection is associated with incomplete liver restoration and splenomegaly a long period after liver resection
    Nguyen Hai Nam, Kojiro Taura, Yusuke Kimura, Yusuke Uemoto, Kenji Yoshino, Ken Fukumitsu, Takamichi Ishii, Satoru Seo, Keiko Iwaisako, Shinji Uemoto
    Surgery.2020; 168(1): 40.     CrossRef
  • Directly induced hepatogenic cells derived from human fibroblast ameliorate liver fibrosis
    Ja Sung Choi, Seongho Han, Hyun Aae Ryu, Sung‐Whan Kim
    Journal of Tissue Engineering and Regenerative Medicine.2020; 14(8): 1028.     CrossRef
  • CDK5RAP3 Deficiency Restrains Liver Regeneration after Partial Hepatectomy Triggering Endoplasmic Reticulum Stress
    Shuchun Yang, Rui Yang, Huanmin Wang, Yue Huang, Yuyan Jia
    The American Journal of Pathology.2020; 190(12): 2403.     CrossRef
  • Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
    Yohan Kim, Kyojin Kang, Seung Bum Lee, Daekwan Seo, Sangtae Yoon, Sung Joo Kim, Kiseok Jang, Yun Kyung Jung, Kyeong Geun Lee, Valentina M. Factor, Jaemin Jeong, Dongho Choi
    Journal of Hepatology.2019; 70(1): 97.     CrossRef
  • The role of extracellular matrix on liver stem cell fate: A dynamic relationship in health and disease
    Natalia Sánchez-Romero, Pilar Sainz-Arnal, Iris Pla-Palacín, Pablo Royo Dachary, Helen Almeida, Cristina Pastor, Daniela Rubio Soto, Milagros Chico Rodriguez, Emma Olmedo Arbizu, Lourdes Bengochea Martinez, Trinidad Serrano-Aulló, Pedro M. Baptista
    Differentiation.2019; 106: 49.     CrossRef
  • CD11b+Ly6G+ myeloid‐derived suppressor cells promote liver regeneration in a murine model of major hepatectomy
    Ido Nachmany, Yoel Bogoch, Ayelet Sivan, Omer Amar, Ekaterina Bondar, Nitzan Zohar, Oran Yakubovsky, Ofer Fainaru, Joseph M. Klausner, Niv Pencovich
    The FASEB Journal.2019; 33(5): 5967.     CrossRef
  • Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
    Juan Li, Ying-Ren Zhao, Zhen Tian
    World Journal of Hepatology.2019; 11(5): 412.     CrossRef
  • Mesenchymal Stem Cells for Liver Regeneration in Liver Failure: From Experimental Models to Clinical Trials
    Maria P. de Miguel, I. Prieto, A. Moratilla, J. Arias, M. A. Aller
    Stem Cells International.2019; 2019: 1.     CrossRef
  • Generation of functional human hepatocytes in vitro: current status and future prospects
    Tomoko Yamaguchi, Juntaro Matsuzaki, Takeshi Katsuda, Yoshimasa Saito, Hidetsugu Saito, Takahiro Ochiya
    Inflammation and Regeneration.2019;[Epub]     CrossRef
  • Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver
    Luis E. Soria-Jasso, Raquel Cariño-Cortés, Víctor Manuel Muñoz-Pérez, Elizabeth Pérez-Hernández, Nury Pérez-Hernández, Eduardo Fernández-Martínez
    International Journal of Molecular Sciences.2019; 20(19): 4694.     CrossRef
  • Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?
    Zeyu Zhang, Kuan Hu, Jiajin Yang, Yufan Zhou, Zhiming Wang, Yun Huang
    Medicine.2019; 98(49): e18176.     CrossRef
  • Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function
    Ji Hu, Peng Li, Yang Song, Yun‐xuan Ge, Xiao‐ming Meng, Cheng Huang, Jun Li, Tao Xu
    Journal of Cellular Physiology.2018; 233(6): 4408.     CrossRef
  • Three-Dimensional Bioprinting of Hepatic Structures with Directly Converted Hepatocyte-Like Cells
    Kyojin Kang, Yohan Kim, Hyeryeon Jeon, Seung Bum Lee, Ji Sook Kim, Su A Park, Wan Doo Kim, Heung Mo Yang, Sung Joo Kim, Jaemin Jeong, Dongho Choi
    Tissue Engineering Part A.2018; 24(7-8): 576.     CrossRef
  • Shaping the future of liver surgery
    D. Pereyra, P. Starlinger
    European Surgery.2018; 50(3): 132.     CrossRef
  • The multiple functions of melatonin in regenerative medicine
    Maryam Majidinia, Russel J. Reiter, Seyed Kazem Shakouri, Iraj Mohebbi, Mojgan Rastegar, Mojtaba Kaviani, Saber Ghazizadeh Darband, Rana Jahanban-Esfahlan, Seyed Mohammad Nabavi, Bahman Yousefi
    Ageing Research Reviews.2018; 45: 33.     CrossRef
  • Associating liver partition and portal vein ligation versus 2-stage hepatectomy
    Yi-Nan Shen, Cheng-Xiang Guo, Lin-Yan Wang, Yao Pan, Yi-Wen Chen, Xue-Li Bai, Ting-Bo Liang
    Medicine.2018; 97(35): e12082.     CrossRef
  • Portal venous velocity affects liver regeneration after right lobe living donor hepatectomy
    Chen-Tai Hou, Yao-Li Chen, Chia-Cheng Lin, Chen-Te Chou, Kuo-Hua Lin, Ping-Yi Lin, Ya-Lan Hsu, Chia-Bang Chen, Hui-Chuan Lin, Chih-Jan Ko, Su-Han Wang, Li-Chueh Weng, Chia-En Hsieh, Gianfranco D. Alpini
    PLOS ONE.2018; 13(9): e0204163.     CrossRef
  • Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells
    Sangtae Yoon, Kyojin Kang, Young-duck Cho, Yohan Kim, Elina Maria Buisson, Ji-Hye Yim, Seung Bum Lee, Ki-Young Ryu, Jaemin Jeong, Dongho Choi
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin
    Hongbo Shi, Yizhi Zhang, Jing Ji, Ping Xu, Honglin Shi, Xiujuan Yue, Feng Ren, Yu Chen, Zhongping Duan, Dexi Chen
    Scientific Reports.2018;[Epub]     CrossRef
  • Low-Power Laser Irradiation (LPLI): A Clinical Point of View on a Promising Strategy to Improve Liver Regeneration
    Tiago Gomes Araújo, Alexandre Gabarra Oliveira, Antonio R. Franchi Teixeira
    Journal of Lasers in Medical Sciences.2018; 9(4): 223.     CrossRef
  • Stereological analysis of size and density of hepatocytes in the porcine liver
    Khan L. Junatas, Zbyněk Tonar, Tereza Kubíková, Václav Liška, Richard Pálek, Patrik Mik, Milena Králíčková, Kirsti Witter
    Journal of Anatomy.2017; 230(4): 575.     CrossRef
  • Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases
    Irina V. Kholodenko, Konstantin N. Yarygin
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
    Fernando Ezquer, Javiera Bahamonde, Ya-Lin Huang, Marcelo Ezquer
    Stem Cell Research & Therapy.2017;[Epub]     CrossRef
  • Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique
    Hyeryeon Jeon, Kyojin Kang, Su A Park, Wan Doo Kim, Seung Sam Paik, Sang-Hun Lee, Jaemin Jeong, Dongho Choi
    Gut and Liver.2017; 11(1): 121.     CrossRef
  • Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure
    Yohan Kim, Kyojin Kang, Jaemin Jeong, Seung Sam Paik, Ji Sook Kim, Su A Park, Wan Doo Kim, Jisun Park, Dongho Choi
    Annals of Surgical Treatment and Research.2017; 92(2): 67.     CrossRef
  • Fabrication and evaluation of SDF-1 loaded galactosylated chitosan nanoparticles for liver targeting
    Chu Xue-Hui, Feng Zhang-Qi, Xu Qian, Xiao Jiang-Qiang, Yuan Xian-Wen, Sun Xi-Tai
    Materials Research Express.2017; 4(3): 035028.     CrossRef
  • Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique
    Han Joon Kim, Jaemin Jeong, Sunhoo Park, Young-Woo Jin, Seung-Sook Lee, Seung Bum Lee, Dongho Choi
    Gut and Liver.2017; 11(2): 261.     CrossRef
  • A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose
    Mette Marie Fode, Kirstine Bak-Fredslund, Jørgen Baltzer Petersen, Esben Worm, Michael Sørensen, Morten Høyer
    Acta Oncologica.2017; 56(11): 1614.     CrossRef
  • Expression of hypoxia inducible factor-1α and its correlation with phosphoenolpyruvate carboxykinase after portal vein ligation in rats
    Changjun Jia, Hua Yang, Chaoliu Dai, Feng Xu, Songlin Peng, Yang Zhao, Chuang Zhao, Liang Zhao
    Life Sciences.2017; 190: 97.     CrossRef
  • MicroRNA-21 Contributes to Liver Regeneration by Targeting PTEN
    Xiaoyu Chen, Meiyi Song, Wei Chen, Jasmina Dimitrova-Shumkovska, Yingying Zhao, Yan Cao, Yang Song, Wenzhuo Yang, Fei Wang, Yang Xiang, Changqing Yang
    Medical Science Monitor.2016; 22: 83.     CrossRef
  • The Role of IL-1 Family Members and Kupffer Cells in Liver Regeneration
    Quanhui Tan, Jianjun Hu, Xiaolan Yu, Wen Guan, Huili Lu, Yan Yu, Yongsheng Yu, Guoqiang Zang, Zhenghao Tang
    BioMed Research International.2016; 2016: 1.     CrossRef
  • An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence
    Yu-Long Cai, Pei-Pei Song, Wei Tang, Nan-Sheng Cheng
    Medicine.2016; 95(24): e3941.     CrossRef
  • Prediction of postoperative liver regeneration from clinical information using a data-led mathematical model
    Kimiyo N. Yamamoto, Masatsugu Ishii, Yoshihiro Inoue, Fumitoshi Hirokawa, Ben D. MacArthur, Akira Nakamura, Hiroshi Haeno, Kazuhisa Uchiyama
    Scientific Reports.2016;[Epub]     CrossRef
  • Functional comparison of human embryonic stem cells and induced pluripotent stem cells as sources of hepatocyte-like cells
    Jaemin Jeong, Kyu Nam Kim, Min Sung Chung, Han Joon Kim
    Tissue Engineering and Regenerative Medicine.2016; 13(6): 740.     CrossRef
  • 16,370 View
  • 228 Download
  • 52 Web of Science
  • Crossref

Original Article

The effect of preconditioning on liver regeneration after hepatic resection in cirrhotic rats
Seon Ok Min, Sung Hoon Kim, Sang Woo Lee, Jin A Cho, Kyung Sik Kim
Korean J Hepatol 2011;17(2):139-147.
Published online June 23, 2011
DOI: https://doi.org/10.3350/kjhep.2011.17.2.139
Background/Aims

Ischemic preconditioning (IP) decreases severity of liver necrosis and has anti-apoptotic effects in previous studies using liver regeneration in normal rats. This study assessed the effect of IP on liver regeneration after hepatic resection in cirrhotic rats.

Methods

To induce liver cirrhosis, thioacetamide (300 mg/kg) was injected intraperitoneally into Sprague-Dawley rats twice per week for 16 weeks. Animals were divided into four groups: non-clamping (NC), total clamping (TC), IP, and intermittent clamping (IC). Ischemic injury was induced by clamping the left portal pedicle including the portal vein and hepatic artery. Liver enzymes alanine transaminase (ALT) and aspartate aminotransferase (AST) were measured to assess liver damage. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining for apoptosis and proliferating cell nuclear antigen (PCNA) staining for cell replication were also performed.

Results

Day-1 ALT and AST were highest in IP, however, levels in NC and IC were comparably low on days 1-7. There was no significant correlation of AST or ALT with experimental groups (P=0.615 and P=0.186). On TUNEL, numbers of apoptotic cells at 100× magnification (cells/field) were 31.8±24.2 in NC, 69.0±72.3 in TC, 80.2±63.1 in IP, and 21.2±20.8 in IC (P<0.05). When regeneration capacity was assessed by PCNA staining, PCNA-positive cells (cells/field) at 400× were 3.4±6.0 in NC, 16.9±69 in TC, 17.0±7.8 in IP and 7.4±7.6 in IC (P<0.05).

Conclusions

Although regeneration capacity in IP is higher than IC, the liver is vulnerable to ischemic damage in cirrhotic rats. Careful consideration is needed in applying IP in the clinical setting.

Citations

Citations to this article as recorded by  Crossref logo
  • Liver ischemia-reperfusion injury: From trigger loading to shot firing
    Eric Felli, Emanuele Felli, Edoardo M. Muttillo, Takeshi Urade, Giovanni G. Laracca, Valerio Giannelli, Simone Famularo, Bernard Geny, Giuseppe M. Ettorre, Krista Rombouts, Massimo Pinzani, Michele Diana, Jordi Gracia-Sancho
    Liver Transplantation.2023; 29(11): 1226.     CrossRef
  • Parenteral Solution of Nutritional Hepatotrophic Factors Improves Regeneration in Thioacetamide-induced Cirrhotic Livers after Partial Hepatectomy
    Mauricio de Rosa Trotta, Dandara Murad Cajaiba, Osório Miguel Parra, Maria Lúcia Zaidan Dagli, Francisco Javier Hernandez-Blazquez
    Toxicologic Pathology.2014; 42(2): 414.     CrossRef
  • 9,511 View
  • 39 Download
  • Crossref

Current status of hepatic surgery in Korea
Kyung Sik Kim
Korean J Hepatol 2009;15(60):60-64.
Published online December 31, 2009
DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S60

Citations

Citations to this article as recorded by  Crossref logo
  • Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
    Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
    Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
  • Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
    Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
    Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
  • A Comparative Analysis of Hepatocellular Carcinoma after Hepatic Resection in Young versus Elderly Patients
    Cho Rok Lee, Jin Hong Lim, Sung Hoon Kim, Sang Hoon Ahn, Young Nyun Park, Gi Hong Choi, Jin Sub Choi, Kyung Sik Kim
    Journal of Gastrointestinal Surgery.2012; 16(9): 1736.     CrossRef
  • 5,521 View
  • 26 Download
  • Crossref
Original Articles
Risk factors for early recurrence after surgical resection for hepatocellular carcinoma
Ui Jun Park, M.D., Yong Hoon Kim, M.D., Koo Jeong Kang, M.D., Tae Jin Lim, M.D.
Korean J Hepatol 2008;14(3):371-380.
Published online September 30, 2008
DOI: https://doi.org/10.3350/kjhep.2008.14.3.371
Background/Aims
Early recurrence (ER) after liver resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aimed to identify the factors associated with ER after curative hepatic resection for HCC. Methods: From the July 2000 to July 2006, 144 patients underwent hepatic resection for HCC at a single institution. After excluding those with ruptured HCC, combined or mixed HCC, and who died during admission, 116 patients were analyzed. Patients with ER (defined as within 1 year) were compared with those who remained free of disease for more than 1 year. Various clinical characteristics including tumor and operative factors were evaluated to determine the factors predicting postoperative ER using univariate and multivariate analyses. Results: ER occurred in 51 patients (44%). In the univariate analysis, tumor size (P=0.001), microvascular invasion (P=0.003), portal vein invasion (P=0.001), TNM stage (P=0.010), serum levels of alpha-fetoprotein (AFP) (P=0.002) and aspartate aminotransferase (AST) (P=0.011), and operative time (P=0.033) were significantly associated with ER. AFP and AST were the independent predictors of ER in the multivariate analysis (P<0.05). Conclusions: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors. (Korean J Hepatol 2008;14:371-380)

Citations

Citations to this article as recorded by  Crossref logo
  • The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Yoichi Yano, Satoru Matsugaki, Etsuko Moriyama, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
    Cancer Medicine.2023; 12(11): 12325.     CrossRef
  • Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis
    Feng Xia, Peng Zhu, Xiao-Ping Chen, Bi-Xiang Zhang, Ming-Yu Zhang, Subhadeep Roy
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • Hepatocellular carcinoma: preoperative gadoxetic acid–enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis
    Su Joa Ahn, Jung Hoon Kim, Sang Joon Park, Seung Tack Kim, Joon Koo Han
    Abdominal Radiology.2019; 44(2): 539.     CrossRef
  • Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm
    Chao Zhang, Xiangmei Chen, Hui Liu, Hui Li, Wei Jiang, Wenting Hou, Michael A. McNutt, Fengmin Lu, Gang Li
    International Journal of Cancer.2015; 137(8): 1818.     CrossRef
  • Metabolic profiling study of early and late recurrence of hepatocellular carcinoma based on liquid chromatography-mass spectrometry
    Lina Zhou, Yuan Liao, Peiyuan Yin, Zhongda Zeng, Jia Li, Xin Lu, Limin Zheng, Guowang Xu
    Journal of Chromatography B.2014; 966: 163.     CrossRef
  • Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt
    Asmaa Ibrahim Gomaa, Mohamed Saad Hashim, Imam Waked, Ferruccio Bonino
    PLoS ONE.2014; 9(3): e90929.     CrossRef
  • Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors
    Hee Young Lee, Hyunchul Rhim, Min Woo Lee, Young-sun Kim, Dongil Choi, Min Jung Park, Young Kon Kim, Seong Hyun Kim, Hyo Keun Lim
    European Radiology.2013; 23(1): 190.     CrossRef
  • Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy
    Ali Muhi, Tomoaki Ichikawa, Utaroh Motosugi, Katsuhiro Sano, Zareen Fatima, Masanori Matsuda, Hideki Fujii, Nobuyuki Enomoto, Tsutomu Araki
    Hepatology International.2013; 7(2): 662.     CrossRef
  • Localized Uterine Recurrence of Hepatocellular Carcinoma 4 Years after Curative Resection
    Sang Jin Lee, Jung Woo Shin, Neung Hwa Park, Yang Won Nah, Hang Jo Yoo, Yoong Ki Jung, Hye Jeong Choi
    Korean Journal of Medicine.2012; 82(5): 603.     CrossRef
  • Impact of intracellular alpha fetoprotein on retinoic acid receptors‐mediated expression of GADD153 in human hepatoma cell lines
    Chaoying Li, Shanshan Wang, Wei Jiang, Hui Li, Zhongmin Liu, Chao Zhang, Michael A. McNutt, Gang Li
    International Journal of Cancer.2012; 130(4): 754.     CrossRef
  • The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
    Qing Zhang, Xinguo Chen, Yunjin Zang, Li Zhang, Hong Chen, Letian Wang, Yujian Niu, Xiuyun Ren, Zhongyang Shen, Lei Shang, Michael Bouchard
    PLoS ONE.2012; 7(12): e50919.     CrossRef
  • Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection
    Myung Hee Yoon, Young Il Choi, Kwang Kuk Park, Dong Hoon Shin, Chung Han Lee
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2011; 15(2): 83.     CrossRef
  • 6,224 View
  • 59 Download
  • Crossref
Effect of Intrasplenic Transplantation of Cryopreserved Hepatocytes into Partially Hepatectomized Rats
Seong Gyu Hwang, M.D., Ik Jin Yun, M.D.2, 3, Yun Soo Kim, M.D.1, 2, Kyung Chul Kim, M.D., Sung Pyo Hong, M.D., Pil Won Park, M.D., Kyu Sung Rim, M.D., Joo Young Cho, M.D.1, 2, Joon Seong Lee, M.D.1, 2, Moon Sung Lee, M.D.1, 2 and Chan Sup Shim, M.D.1, 2
Korean J Hepatol 1999;5(2):116-123.
Background/Aims
: Various techniques of hepatocyte transplantation were actively studied as an alternative to liver transplantation, because of the difficulty of obtaining donor organ, technical difficulties, and high cost. Isolated hepatocytes could be appropriately banked and distributed on demand. We tried to investigate the effect of intrasplenic transplantation of allogenic cryopreserved hepatocytes, into spleen prior to 90% partial hepatectomy in rats, on the survival rate. Methods : Cryopreserved hepatocytes, isolated by collagenase perfusion of the liver via the portal vein, were thawed and transplanted into the spleen of rats prior to induction of acute hepatic failure by resection of all lobes except caudate lobe (2.0×107 hepatocytes/rat). Results : 1. The viability of freshly isolated hepatocyte was 70-85%, but cell viability after cryopreservation 30-50%. 2. Difference of survival in control and transplant group is not statistically significant. but the survival rate, 48 hours after 90% partial hepatectomy, for control (7) and transplanted group (11) were 0% and 18%, respectively. 3. Although the glucose reduction gradient was not significantly different between two groups, it was more prominent in the control group than in the transplanted group. 4. Engraftment and survival of transplanted hepatocytes were noted in the spleen 2 days after transplantation. Conclusions : We could not observe statistically significant improvement of survival with intrasplenic transplantation of cryopreserved hepatocytes in rats with 90% partial hepatectomy-induced acute liver failure. However, 18% survival after 90% partial hepatectomy was noted in the transplanted group, compared to no survival in the control group. This suggests that intrasplenic transplantation of cryopreserved hepatocytes might be effective in the treatment of acute liver failure. (Korean J Hepatol 1999;5:116-123)
  • 2,676 View
  • 17 Download
Risk Factors of Morbidity and Mortality Following Surgical Resection for Hepatocellular Carcinoma
Wan Wook Kim, M.D., Kwang-Woong Lee, M.D., Sung Ho Choi, M.D., Jin Seok Heo, M.D., Yong Il Kim, M.D., Sung Ju Kim, M.D., Dae Sung Lee, M.D., Hwan Hyo Lee, M.D., Seung Woon Paik, M.D.1, Kwang Cheol Koh, M.D.1, Joon Hyoek Lee, M.D.1, Moon Seok Choi, M.D.1 , Byung Chul Yoo, M.D.1 and Jae Won Joh, M.D.
Korean J Hepatol 2004;10(1):51-61.
Background/Aims
Recently, mortality following surgical resection for hepatocelluar carcinoma has been reduced significantly. Morbidity, however, is still significant. This study evaluated the risk factors leading to morbidity and mortality. Methods: 510 patients who had a hepatic resection form Nov. 1994 to Dec. 2001 were included. The patient demographics showed a mean age of 51.6 years with a male to female ratio of 4:1. The HBsAg was positive in 76.0% and the anti-HCV was positive in 8.2%. The mean tumor size was 5.2 cm, 26.2% of patients had preoperative transcatheter arterial embolization (TAE), and 8.7% had preoperative percutaneous transhepatic portal embolization (PTPE). Limited resection was performed in 259 cases (50.7%), and major resection was conducted in 251 cases (49.1%). Risk factors included age, sex, laboratory findings (liver function test, prothrombin time, albumin, glucose, α-fetoprotein, ICG test), preoperative TAE, PTPE, operation type, operation time, intraoperative transfusion, tumor size, and cirrhosis.
Results
The morbidity was 10.5% (54 cases). Operative death occurred in 5 cases (1.0%). Hospital death, including operative death, occurred in 6 cases (1.2%). Five cases were associated with hepatic failure and 1 case was associated with aspiration pneumonia accompanying hepatic failure. Transfusion (P=0.002), glucose (P=0.002), and prothrombin time (P=0.038) were significantly related to morbidity. Age (P=0.028), glucose (P=0.011), and TAE (P=0.046) were significantly related to mortality. Conclusions: Intraoperative transfusion, which is mainly related to intraoperative bleeding, should be reduced if possible to decrease morbidity. Diabetes mellitus patients and the elderly need careful perioperative management.(Korean J Hepatol 2004;10:51-61)
  • 3,741 View
  • 20 Download
Clinical Features of Surgically Resected Focal Nodular Hyperplasia of the Liver
Nam Cheol Hwang, M.D., Moon Seok Choi, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Seung Woon Paik, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D., Kwang-Woong Lee, M.D.*, Jae-Won Joh, M.D.* and Cheol Keun Park, M.D.
Korean J Hepatol 2004;10(2):135-141.
Background/Aims
Focal nodular hyperplasia (FNH) is a benign hepatic tumor with few serious complications and no malignant transformation. However, differential diagnosis between FNH and other liver tumors, especially hepatocellular carcinoma, is often difficult. Methods: Clinical features of surgically resected FNH were reviewed. From January, 1995 to February, 2003, 10 patients with surgically resected FNH were enrolled. Their age, sex, results of laboratory examination, imaging studies and pathologic findings were evaluated. Results: Median age was 37.5 years and sex ratio (male:female) was 1.5:1. In 5 cases, resection to exclude hepatic adenoma or HCC was performed. Four cases were diagnosed incidentally after surgery. Four patients had risk factors for HCC, such as hepatitis B virus infection, liver cirrhosis or both. The size of FNH was 3.2 2.2 cm. The most common site of the tumor was segment 6 (30.0%). Differential diagnosis with HCC was difficult in 5 of six cases in whom CT was performed. Although needle biopsies were performed preoperatively in 4 cases, it was difficult to distinguish FNH from hepatic adenoma or HCC. Conclusions: FNH was resected due to uncertainty of diagnosis, or incidentally during hepatectomy in patients with other liver disease. In the former, differential diagnosis with hepatic adenoma or HCC was a major problem despite extensive work-up including dynamic CT or biopsy. (Korean J Hepatol 2004;10:135-141)
  • 3,510 View
  • 15 Download